Logo image of TARS

TARSUS PHARMACEUTICALS INC (TARS) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:TARS - US87650L1035 - Common Stock

73.65 USD
-1.58 (-2.1%)
Last: 1/15/2026, 8:19:31 PM
73.28 USD
-0.37 (-0.5%)
After Hours: 1/15/2026, 8:19:31 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
TARS revenue by date.TARS revenue by date.
25.82M
-54.73%
17.447M
-32.43%
182.953M
948.62%
452.34M
147.24%
692.58M
53.11%
898.81M
29.78%
1.019B
13.37%
1.205B
18.25%
1.307B
8.46%
1.485B
13.62%
1.583B
6.60%
1.658B
4.74%
EBITDA
YoY % growth
TARS ebitda by date.TARS ebitda by date.
-62.38M
-426.41%
-142.281M
-128.09%
-119.344M
16.12%
-64.784M
45.72%
86.424M
233.40%
268.06M
210.17%
476.95M
77.93%
705.74M
47.97%
787.64M
11.60%
854.66M
8.51%
923.41M
8.04%
1.028B
11.33%
EBIT
YoY % growth
TARS ebit by date.TARS ebit by date.
-62.71M
-415.71%
-143.158M
-128.29%
-120.569M
15.78%
-69.63M
42.25%
80.82M
216.07%
262.37M
224.63%
401.32M
52.96%
578.42M
44.13%
671.61M
16.11%
823.44M
22.61%
900.19M
9.32%
967.86M
7.52%
Operating Margin
TARS operating margin by date.TARS operating margin by date.
-242.87%-820.53%-65.90%-15.39%11.67%29.19%39.38%48.00%51.39%55.45%56.87%58.38%
EPS
YoY % growth
TARS eps by date.TARS eps by date.
-2.55
-275.00%
-4.64
-81.96%
-3.10
33.19%
-1.50
51.69%
1.78
219.08%
4.70
163.29%
5.69
21.15%
8.35
46.86%
9.71
16.28%
11.19
15.24%
12.22
9.16%
13.52
10.64%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.09
85.79%
-0.01
99.17%
0.37
176.88%
0.53
277.21%
0.73
956.87%
0.64
12,215.38%
0.98
165.34%
1.06
99.54%
1.23
68.99%
Revenue
Q2Q % growth
146.66M
120.85%
151.57M
93.49%
175.45M
70.90%
185.62M
56.38%
190.7M
30.03%
207.68M
37.02%
230.07M
31.13%
245.83M
32.44%
260.66M
36.69%
EBITDA
Q2Q % growth
-3.844M
83.43%
-12.669M
50.93%
23.557M
210.75%
38.311M
391.21%
N/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-1.757M
92.80%
1.746M
106.64%
20.888M
194.16%
29.502M
303.06%
35.234M
2,105.06%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.30
50.82%
-0.360.0616.07%
Q2 2025
Q2Q % growth
-0.48
45.45%
-0.41-0.07-17.77%
Q1 2025
Q2Q % growth
-0.64
36.63%
-0.750.1114.11%
Q4 2024
Q2Q % growth
-0.60
54.20%
-0.760.1620.78%
Q3 2024
Q2Q % growth
-0.61
52.34%
-0.990.3838.50%
Q2 2024
Q2Q % growth
-0.88
24.79%
-0.940.066.62%
Q1 2024
Q2Q % growth
-1.01
-14.77%
-1.230.2217.81%
Q4 2023
Q2Q % growth
-1.31
-167.35%
-1.390.085.75%
Q3 2023
Q2Q % growth
-1.28
-52.38%
-1.390.118.10%
Q2 2023
Q2Q % growth
-1.17
-387.50%
-1.10-0.07-6.36%
Q1 2023
Q2Q % growth
-0.88
10.20%
-0.960.088.70%
Q4 2022
Q2Q % growth
-0.49
31.94%
-0.700.2130.38%
Q3 2022
Q2Q % growth
-0.84
-10.53%
-0.990.1515.35%
Q2 2022
Q2Q % growth
-0.24
-172.73%
-0.600.3660.15%
Q1 2022
Q2Q % growth
-0.98
-308.51%
-0.94-0.04-4.68%
Q4 2021
Q2Q % growth
-0.72
-5.88%
-0.740.022.98%
Q3 2021
Q2Q % growth
-0.76
79.51%
-0.44-0.32-71.68%
Q2 2021
Q2Q % growth
0.33 -0.490.82167.87%
Q1 2021
Q2Q % growth
0.47 -0.651.12172.00%
Q4 2020
Q2Q % growth
-0.68 -0.67-0.01-1.01%
Q3 2020
Q2Q % growth
-3.71 -0.54-3.17-586.27%
TARS Yearly EPS VS EstimatesTARS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 10
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
118.697M
146.68%
117.53M1.167M0.99%
Q2 2025
Q2Q % growth
102.66M
151.54%
97.596M5.064M5.19%
Q1 2025
Q2Q % growth
78.335M
183.68%
73.917M4.418M5.98%
Q4 2024
Q2Q % growth
66.408M
407.86%
59.494M6.914M11.62%
Q3 2024
Q2Q % growth
48.118M
2,471.78%
44.306M3.812M8.60%
Q2 2024
Q2Q % growth
40.813M 32.297M8.516M26.37%
Q1 2024
Q2Q % growth
27.614M
1,004.56%
17.805M9.809M55.09%
Q4 2023
Q2Q % growth
13.076M
30.76%
5.778M7.298M126.31%
Q3 2023
Q2Q % growth
1.871M 407.796K1.463M358.81%
Q2 2023
Q2Q % growth

-100.00%
1.795M-1.795M-100.00%
Q1 2023
Q2Q % growth
2.5M
362.96%
3.188M-688K-21.58%
Q4 2022
Q2Q % growth
10M
2,841.18%
10.2M-200K-1.96%
Q3 2022
Q2Q % growth

-100.00%
2.975M-2.975M-100.00%
Q2 2022
Q2Q % growth
15.28M
-30.61%
13.26M2.02M15.23%
Q1 2022
Q2Q % growth
540K
-98.38%
2.244M-1.704M-75.94%
Q4 2021
Q2Q % growth
340K 6.204M-5.864M-94.52%
Q3 2021
Q2Q % growth
1.24M 5.44M-4.2M-77.21%
Q2 2021
Q2Q % growth
22.02M 4.624M17.396M376.21%
TARS Yearly Revenue VS EstimatesTARS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS13.18% -9.95% 2.37% -2.91%
Revenue0% 9.2% 0% 4.2%